SELLAS Life Sciences Group, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-11.9M | $-11.9M | $6.0K | $354.0K |
| FY2017 | $-11.0M | $-11.0M | — | $3.2M |
| FY2018 | $-30.4M | $-30.4M | — | $395.0K |
| FY2019 | $-17.6M | $-17.6M | — | $573.0K |
| FY2020 | $-10.4M | $-10.4M | — | $578.0K |
| FY2021 | $-26.0M | $-26.0M | — | $1.0M |
| FY2022 | $-23.8M | $-23.8M | — | $1.7M |
| FY2023 | $-31.4M | $-31.4M | — | $2.1M |
| FY2024 | $-35.4M | $-35.4M | — | $1.6M |
| FY2025 | $-28.4M | $-28.4M | — | $2.0M |